Sage Therapeutics (NASDAQ:SAGE) Earnings Information
Sage Therapeutics last issued its earnings results on February 24th, 2021. The biopharmaceutical company reported $18.19 EPS for the quarter, beating analysts' consensus estimates of ($2.17) by $20.36. Sage Therapeutics has generated ($13.38) earnings per share over the last year. Sage Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.
Sage Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Sage Therapeutics (NASDAQ:SAGE) Earnings Estimates
2021 EPS Consensus Estimate: ($8.90)
Sage Therapeutics (NASDAQ SAGE) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)